Trials / Unknown
UnknownNCT03121053
Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
Preventing Contrast Induced Nephropathy After Transcatheter Aortic Valve Replacement
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- St. Antonius Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Chronic kidney disease (CKD) and (subsequent) acute kidney injury are frequent in patients undergoing transcatheter aortic valve implantation (TAVI). Moreover, these patients are easily hypervolemic and susceptible for cardiac decompensation. Prevention of contrast induced nephropathy (CIN) has not yet been studied in these patients, and evidence on different strategies is urgently needed. The objective of this study is to evaluate the efficacy of 250ml 1.4% sodium bicarbonate versus hypotone saline (0.65% sodiumchloride) hydration prior to TAVI in patients with CKD to prevent CIN.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sodium bicarbonate | |
| DRUG | hypotone saline |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-12-01
- Completion
- 2019-01-01
- First posted
- 2017-04-19
- Last updated
- 2017-04-19
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03121053. Inclusion in this directory is not an endorsement.